Results demonstrated that the investigational combination of TECENTRIQ ® (atezolizumab) plus ABRAXANE ® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) compared to ...

APP has licensed the exclusive North American manufacturing and marketing rights for ABRAXANE. American BioScience, Inc. is a privately held biotechnology company focused on the discovery ...

ABRAXANE achieved a similar overall response ... is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for ...

Paclitaxel is indicated for the treatment of metastatic breast cancer, metastatic adenocarcinoma of the pancreas and locally ...

ABRAXANE ® is not approved for the treatment ... is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies ...

Celgene Corporation ( CELG) announced that it has received approval from the U.S. Food and Drug Administration (FDA) for a label expansion of its cancer drug, Abraxane. Celgene gained approval for ...

Celgene was looking to take advantage of this sentiment when the company acquired Abraxis BioScience and their leading drug candidate, Abraxane®, an injectable suspension of nanoparticle albumin ...

Dr. Patrick Soon-Shiong, the creator of Abraxane® and the founder of the ... broaden the scope of scientific discovery, enhance groundbreaking research, and improve healthcare treatment for ...

The MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study was an open-label, randomized, international study in which 861 metastatic pancreatic cancer patients were randomized to ...

The buyout gives Celgene control of Abraxane, now approved for breast cancer treatment, along with its discovery platform and a pipeline of experimental therapies. In exchange for every share of ...

American Pharmaceutical Partners Inc. said the Food and Drug Administration approved Abraxane, an apparently less toxic form of a traditional chemotherapy drug, to treat metastatic breast cancer.